Sudeep Pharma
add_icon

Sudeep Pharma

687.20
+13.05
(1.94%)
Market Cap
₹7,761.80 Cr
PE Ratio
55.89
Volume
4,17,332.00
Day High - Low
₹695.00 - ₹665.50
52W High-Low
₹795.00 - ₹631.45
hide
Key Fundamentals
Add Ratio
split_icon_default
Market Cap
7,761.80 Cr
EPS
12.79
PB Ratio
13.20
Book Value
51.99
EBITDA
199.30
Dividend Yield
0.00 %
Industry
Healthcare
Return on Equity
28.13
Debt to Equity
0.25
Forecast For
Actual

Company News

View All News
Caret
neutral
Sudeep Pharma Limited announces Q2FY26 results presentation and earnings call scheduled for December 22, 2025, to discuss operational and financial performance for quarter and half-year ended September 30, 2025.
negative
Sudeep Pharma's Q2 EBITDA declined to ₹55.5 crores from ₹63.5 crores YoY, with EBITDA margin compressing to 34.09% from 42.66%. Net profit also dropped 6.2% to ₹45.70 crores despite 6.7% revenue growth.
neutral
Sudeep Pharma Limited published its Q2FY26 financial results extract in newspapers following regulatory compliance under SEBI LODR Regulations.
View more
Competitors
LTP
Market Cap (₹ Cr.)
P/E Ratio
Revenue (₹ Cr.)
YoY Revenue Growth %
Net Profit (₹ Cr.)
YoY Profit Growth %
RSI
1,744.90
#1 4,18,659.96
39.94
#1 54,729.00
9.71
#1 10,980
2.89
42.57
6,478.50
1,71,983.82
68.16
9,712.00
18.67
2,191
35.10
54.31
3,800.30
1,28,619.42
59.46
11,539.40
6.99
1,911
30.46
59.28
1,517.10
1,22,544.37
22.28
28,409.50
7.12
5,291
3.71
51.13
1,278.20
1,06,680.33
18.62
33,741.20
16.73
5,725
-0.38
57.95
2,125.80
97,096.88
22.26
22,909.50
13.74
3,306
#1 72.75
65.19
919.60
92,533.28
#1 18.28
23,511.00
18.55
4,615
34.60
40.83
2,172.10
89,655.27
49.87
12,744.20
#1 20.90
2,007
-21.05
42.47
1,225.10
71,154.01
20.54
32,345.60
9.43
3,484
3.81
60.10
5,555.50
66,424.34
27.37
13,458.30
3.70
2,216
10.98
43.27
Growth Rate
Revenue Growth
9.86 %
Net Income Growth
4.13 %
Cash Flow Change
-25.82 %
ROE
-24.83 %
ROCE
-26.70 %
EBITDA Margin (Avg.)
-3.40 %

Quarterly Financial Results

Quarterly Financials
Jun 2024
Sept 2024
Jun 2025
Sept 2025
Revenue
81
151
130
173
Expenses
52
85
81
107
EBITDA
30
65
49
66
Operating Profit %
35 %
43 %
35 %
34 %
Depreciation
3
3
3
4
Interest
2
1
2
2
Profit Before Tax
26
62
44
60
Tax
9
13
13
13
Net Profit
17
49
31
47
EPS in ₹
4.49
4.49
2.80
4.20

Balance Sheet

Balance Sheet
2021
2022
2024
2025
Total Assets
213
344
514
717
Fixed Assets
68
137
180
189
Current Assets
100
197
275
424
Capital Work in Progress
24
8
45
88
Investments
0
0
0
0
Other Assets
121
199
289
440
Total Liabilities
213
344
514
717
Current Liabilities
80
147
137
175
Non Current Liabilities
19
34
21
49
Total Equity
114
163
356
493
Reserve & Surplus
113
162
355
481
Share Capital
1
1
1
12

Cash Flow

Cash Flow
2020
2021
2022
2024
2025
Net Cash Flow
-0
8
10
4
23
Investing Activities
-23
-40
-38
-49
-79
Operating Activities
10
35
-3
66
49
Financing Activities
12
13
51
-13
53

Share Holding

% Holding
Jun 2025
Nov 2025
Promoter
91.07 %
76.15 %
FIIs
0.00 %
1.54 %
DIIs
0.00 %
14.76 %
Government
0.00 %
0.00 %
Public / Retail
0.00 %
7.52 %
Others
8.93 %
0.02 %
No of Share Holders
0
16

Corporate Action

Record Date Corporate Action Information Announcement Day LTP at Annoucement LTP at Record Day
19 Dec 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
19 Dec 2025 698.20 672.95

Mutual Fund Holdings

Funding HouseCurrent Holding %1M Change1M Change %3M Change %Last 6M Trend
SBI Healthcare Opportunities Fund Direct Plan-Growth
0.72%
385199
0.72%
0.72%
Aditya Birla Sun Life Small Cap Fund Direct-Growth
0.54%
354125
0.54%
0.54%
ICICI Prudential MNC Fund Direct - Growth
1.57%
354125
1.57%
1.57%
Nippon India Flexi Cap Fund Direct - Growth
0.28%
354125
0.28%
0.28%
HDFC Manufacturing Fund Direct - Growth
0.23%
336075
0.23%
0.23%
Axis Small Cap Fund Direct-Growth
0.09%
314749
0.09%
0.09%
Axis Multi Asset Allocation Direct Plan -Growth
1.00%
230288
1.00%
1.00%
Motilal Oswal Large Cap Fund Direct - Growth
0.53%
206891
0.53%
0.53%
Bandhan Small Cap Fund Direct-Growth
0.09%
204900
0.09%
0.09%
UTI Healthcare Fund Direct-Growth
1.41%
204900
1.41%
1.41%
Mirae Asset Healthcare Fund Direct - Growth
0.56%
204900
0.56%
0.56%
WhiteOak Capital Flexi Cap Fund Direct - Growth
0.19%
172239
0.19%
0.19%
Edelweiss Recently Listed IPO Fund Direct-Growth
1.27%
156127
1.27%
1.27%
HDFC Innovation Fund Direct-Growth
0.33%
118050
0.33%
0.33%
WhiteOak Capital Pharma and Healthcare Fund Direct - Growth
1.57%
101833
1.57%
1.57%
WhiteOak Capital Multi Cap Fund Direct - Growth
0.19%
70884
0.19%
0.19%
Edelweiss Equity Savings Fund Direct-Growth
0.47%
67595
0.47%
0.47%
WhiteOak Capital Multi Asset Allocation Fund Direct - Growth
0.09%
58713
0.09%
0.09%
WhiteOak Capital Balanced Advantage Fund Direct - Growth
0.11%
28650
0.11%
0.11%
WhiteOak Capital ELSS Tax Saver Fund Direct - Growth
0.20%
11474
0.20%
0.20%
WhiteOak Capital Balanced Hybrid Fund Direct - Growth
0.05%
1683
0.05%
0.05%

Technical Indicators

RSI(14)
Neutral
32.10
ATR(14)
Less Volatile
35.13
STOCH(9,6)
Neutral
51.26
STOCH RSI(14)
Oversold
0.00
MACD(12,26)
Bearish
0.00
ADX(14)
Weak Trend
0.00
UO(9)
Bullish
0.00
ROC(12)
Uptrend And Accelerating
0.89
WillR(14)
Neutral
-50.55